JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (38) Citing Articles via Google Scholar Google Scholar Articles by Harada, H. Articles by Patel, P. M. Search for Related Content PubMed PubMed Citation Articles by Harada, H. Articles by Patel, P. M.

---

NEUROSURGICAL ANESTHESIA

Isoflurane Reduces N-Methyl-D-Aspartate Toxicity In Vivo in the Rat Cerebral Cortex

Hideki Harada, MD, Paul J. Kelly, BS^*,*, Daniel J. Cole, MD, John C. Drummond, MD, FRCPC^*,*, and Piyush M. Patel, MD, FRCPC^*,*

*Departments of Anesthesiology, University of California; *Department of Veterans Affairs, Veterans Affairs Medical Center, San Diego, California; Department of Anesthesiology, Kurume University School of Medicine, Kurume, Japan; and Department of Anesthesiology, Loma Linda University, Loma Linda, California

Address correspondence and reprint requests to Piyush M. Patel, Anesthesia Service 9125, VA Medical Center, 3350 La Jolla Village Dr., San Diego, CA 92161. Address e-mail to ppatel{at}ucsd.edu

Recent in vitro data indicate that isoflurane can reduce N-methyl-D-aspartate (NMDA) receptor-mediated responses and thereby might reduce excitotoxicity. However, the effect of isoflurane on NMDA receptor-mediated toxicity in vivo is not known. We conducted the present study to evaluate the effect of isoflurane on injury produced by cortical injection of NMDA in vivo and to compare it with dizocilpine, an antagonist of the NMDA receptor. Fasted Wistar-Kyoto rats were anesthetized with isoflurane. NMDA 50 nmoles (5-µL volume) were stereotactically injected into the cortex (2.8 mm lateral and 2.8 mm rostral to the bregma, depth 2 mm) of animals in one of four groups. In the isoflurane groups, the end-tidal concentration of isoflurane was maintained at either electroencephalogram (EEG)-burst suppression (BS) doses (2.2%–2.3%, n = 12) or a 1 minimum alveolar anesthetic concentration (MAC) dose (n = 10). In the dizocilpine group (n = 10), 10 mg/kg dizocilpine was injected IV 15 min before the NMDA injection. In the awake group and the dizocilpine group, anesthesia was discontinued on completion of the NMDA injection, and the animals were allowed to awaken. In the animals in the control group (n = 10), 20 µL of artificial cerebrospinal fluid was injected into the cortex. Injury to the cortex was evaluated 2 days after the NMDA injection. In 1 MAC doses and EEG-BS doses, isoflurane reduced the injury produced by a cortical NMDA injection compared with the awake state (1.74 ± 0.49 and 0.96 ± 0.46 vs 2.34 ± 0.56 mm³; P = 0.02). Dizocilpine reduced cortical injury (0.56 ± 0.27; P = 0.01) compared with the awake state. Injury in the control group was limited to the trauma produced by cannula insertion. In the isoflurane EEG-BS and dizocilpine groups, the injury was not different from the control group.

Implications: Isoflurane can reduce N-methyl-D-aspartate–mediated cortical injury in vivo in a dose-dependent manner. These data are consistent with the previously demonstrated ability of isoflurane to reduce N-methyl-D-aspartate receptor-mediated responses in vitro.

This article has been cited by other articles:

				S. Fukuda and D. S. Warner Cerebral protection Br. J. Anaesth., July 1, 2007; 99(1): 10 - 17. [Abstract] [Full Text] [PDF]

				I. Nasu, N. Yokoo, S. Takaoka, K. Takata, T. Hoshikawa, M. Okada, and Y. Miura The dose-dependent effects of isoflurane on outcome from severe forebrain ischemia in the rat. Anesth. Analg., August 1, 2006; 103(2): 413 - 8, table of contents. [Abstract] [Full Text] [PDF]

				K. Solt, E. I. Eger II, and D. E. Raines Differential Modulation of Human N-Methyl-d-Aspartate Receptors by Structurally Diverse General Anesthetics. Anesth. Analg., May 1, 2006; 102(5): 1407 - 1411. [Abstract] [Full Text] [PDF]

				S. Inoue, D. P. Davis, J. C. Drummond, D. J. Cole, and P. M. Patel The combination of isoflurane and caspase 8 inhibition results in sustained neuroprotection in rats subject to focal cerebral ischemia. Anesth. Analg., May 1, 2006; 102(5): 1548 - 1555. [Abstract] [Full Text] [PDF]

				L. Wise-Faberowski, M. Aono, R. D. Pearlstein, and D. S. Warner Apoptosis Is Not Enhanced in Primary Mixed Neuronal/Glial Cultures Protected by Isoflurane AgainstN-Methyl-D-Aspartate Excitotoxicity Anesth. Analg., December 1, 2004; 99(6): 1708 - 1714. [Abstract] [Full Text] [PDF]

				M. Kawaguchi, J. C. Drummond, D. J. Cole, P. J. Kelly, M. P. Spurlock, and P. M. Patel Effect of Isoflurane on Neuronal Apoptosis in Rats Subjected to Focal Cerebral Ischemia Anesth. Analg., March 1, 2004; 98(3): 798 - 805. [Abstract] [Full Text] [PDF]

				D. Ma, S. Wilhelm, M. Maze, and N. P. Franks Neuroprotective and neurotoxic properties of the 'inert' gas, xenon Br. J. Anaesth., November 1, 2002; 89(5): 739 - 746. [Abstract] [Full Text] [PDF]

Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999